1210270

METACEL PHARMACEUTICALS LLC — FEI 3015887927

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 28, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Watkinsville, GA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)